Researchers have found in a new study that Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) has long-term effects on cardiovascular function beyond the acute phase.

Good day, ladies and gentlemen, and welcome to the Dynavax Technologies fourth quarter and full year 2024 financial results ...

Four young children have gained life-changing improvements in sight following treatment with a pioneering new genetic ...

A groundbreaking gene therapy has restored sight in four young children born with severe blindness due to a rare genetic deficiency. Scientists at UCL and Moorfields Eye Hospital successfully injected ...

Novadip Biosciences’s bone grafting material NVDX3 has seen all patients achieve bone fracture union in a 12-month Phase ...

Ionis relies on upfront payments and licensing fees from partners, as well as Spinraza royalties, to drive revenue today, but its rapidly advancing portfolio should help diversify revenue. 2025 is ...

EQS-News: ABVC BioPharma, Inc. / Key word (s): Manufacturing ABVC BioPharma Announces Potential $7M Cash Licensing Income from Existing Agreements in 2025 20.02.2025 / 15:04 CET/CEST The issuer is ...

Among patients with pulmonary arterial hypertension treated with 72-week seralutinib, those deemed responders had more improved measures, according to a poster presented at the Pulmonary Vascular ...

The market's underestimating how well each of these companies should be able to capitalize on their opportunities.

DURHAM, N.C., Feb. 20, 2025 (GLOBE NEWSWIRE) -- The Society for Clinical Research Sites (SCRS) and Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), are pleased to ...

A high omega-3, low omega-6 diet with fish oil led to a significant reduction in a biomarker for prostate cancer progression ...